Sun Pharma Strikes $11.75 Billion All-Cash Deal for Organon, the Largest Overseas Acquisition Ever by an Indian Drugmaker
India's Sun Pharma will buy Merck spinoff Organon for $14 a share, vaulting into the global top 25 pharmaceutical companies and entering biosimilars at scale.
4 min read4 sources